Triple synchronous primary neoplasms in the gastrointestinal tract

Matsuda et al[2] reported no significant difference in overall five years survival between the neoadjuvant chemotherapy followed by surgery and upfront surgery (P = 0.167). Chen et al[3] also found no survival difference between neoadjuvant chemoradiation followed by surgery and the upfront surgery with pathological stage-based adjuvant chemo-radiation (P = 0.147). [...]we report our case to highlight that healthcare professionals need special strategies for the management of multiple primary malignancies to provide the best oncological outcomes.